Search

Author/Creator Tetzlaff, Kay

1. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Issue 5 (May 2016)

Authors:
Watz, Henrik; Tetzlaff, Kay; Wouters, Emiel F M; Kirsten, Anne; Magnussen, Helgo; Rodriguez-Roisin, Roberto; Vogelmeier, Claus; Fabbri, Leonardo M; Chanez, Pascal; Dahl, Ronald; Disse, Bernd; Finnigan, Helen; Calverley, Peter M A
Journal:
Lancet
Issue:
Volume 4:Issue 5(2016)
Page Start:
390
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol. (December 2017)

Authors:
Koch, Andrea; Watz, Henrik; Maleki-Yazdi, M.; Bothner, Ulrich; Tetzlaff, Kay; Voß, Florian; McGarvey, Lorcan
Journal:
NPJ primary care respiratory medicine
Issue:
Volume 27(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease. (6th February 2018)

Authors:
Maltais, François; O'Donnell, Denis; Gáldiz Iturri, Juan Bautista; Kirsten, Anne-Marie; Singh, Dave; Hamilton, Alan; Tetzlaff, Kay; Zhao, Yihua; Casaburi, Richard
Journal:
Therapeutic advances in respiratory disease
Issue:
Volume 12(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. (June 2015)

Authors:
Hall, Ian P.; Fowler, Andrew V.; Gupta, Abhya; Tetzlaff, Kay; Nivens, Michael C.; Sarno, Maria; Finnigan, Helen A.; Bateman, Eric D.; Rand Sutherland, E.
Journal:
Pulmonary pharmacology & therapeutics
Issue:
Volume 32(2015:Jun.)
Page Start:
37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD. Issue 2 (19th November 2015)

Authors:
Magnussen, Helgo; Tetzlaff, Kay; Bateman, Eric D.; Watz, Henrik; Kirsten, Anne M.; Wouters, Emiel F.M.; Disse, Bernd; Finnigan, Helen; Rodriguez-Roisin, Roberto; Calverley, Peter M.A.
Journal:
European respiratory journal
Issue:
Volume 47:Issue 2(2016)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis. (3rd September 2015)

Authors:
McGarvey, Lorcan; Niewoehner, Dennis; Magder, Sheldon; Sachs, Paul; Tetzlaff, Kay; Hamilton, Alan; Korducki, Lawrence; Bothner, Ulrich; Vogelmeier, Claus; Koch, Andrea; Ferguson, Gary T.
Journal:
COPD
Issue:
Volume 12:Number 5(2015:Oct.)
Page Start:
484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease. Issue 2 (21st June 2021)

Authors:
Deterding, Robin; Griese, Matthias; Deutsch, Gail; Warburton, David; DeBoer, Emily M.; Cunningham, Steven; Clement, Annick; Schwerk, Nicolaus; Flaherty, Kevin R.; Brown, Kevin K.; Voss, Florian; Schmid, Ulrike; Schlenker-Herceg, Rozsa; Verri, Daniela; Dumistracel, Mihaela; Schiwek, Marilisa; Stow...
Journal:
ERJ open research
Issue:
Volume 7:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗